Betaine-linked one-carbon metabolism in demyelinating neuroinflammation: evidence boundaries and testable predictions for multiple sclerosis

Abstract Background Multiple sclerosis (MS) involves peripheral immune activation, central nervous system (CNS) inflammation, and incomplete repair. This narrative review integrates evidence on betaine-linked one-carbon metabolism across adaptive immunity, lesion-associated myeloid cells, and the oligodendrocyte lineage to identify supported mechanisms, unresolved connections, and priorities for experimental validation. Main body Betaine contributes to systemic homocysteine remethylation through betaine-homocysteine methyltransferase (BHMT), which is expressed predominantly in the liver and kidney. In a high-dose experimental autoimmune encephalomyelitis (EAE) study, preventive betaine treatment reduced disease severity, dendritic cell interleukin-6 production, and T helper 17 (Th17) differentiation; treatment after disease onset did not improve established disease. Independent methionine restriction experiments demonstrated regulation of T-cell S-adenosylmethionine availability and inflammatory chromatin programming. Together, these studies identify immune signaling and methionine-dependent epigenetic regulation as complementary subjects for mechanistic investigation, with cellular activation state and methylation target guiding interpretation. Studies using cuprizone models reported metabolic, neuronal, inflammatory, and structural outcomes, while oligodendrocyte experiments identified maturation-related molecular responses. Betaine studies in predominantly non-MS microglial models provide a rationale for examining inflammatory signaling in demyelinating settings. A descriptive audit of selected public human brain transcript resources identified sparse BHMT transcript detection, informing priorities for protein localization and enzyme activity studies in MS lesion cells. Human dietary and metabolite studies provide association-level evidence, while human pharmacology characterizes systemic exposure and biochemical responses and informs safety monitoring. Conclusions This review integrates the available evidence into a testable framework that distinguishes systemic metabolism from cell-intrinsic mechanisms and considers cellular activation state. The examined EAE evidence identifies dendritic cell-derived interleukin-6 as an experimentally supported betaine-linked immune entry point, while hepatic mediation remains a separate hypothesis. Matched interventions, cell-resolved flux measurements, and selective perturbations would help distinguish immune modulation, tissue preservation, and remyelination. This framework provides a focused research agenda for determining whether and how betaine-linked metabolism influences demyelinating neuroinflammation and its relevance to MS.

Authors

Institutions

Publication Details

Journal
Journal of Neuroinflammation
Published
2026-11-17
DOI
https://doi.org/10.1186/s12974-026-04128-z
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Betaine-linked one-carbon metabolism in demyelinating neuroinflammation: evidence boundaries and testable predictions for multiple sclerosis

Lin-Yun Chen, Jie-Qiong Lu, Xiangming Ye, Yuehua Fei et al.
3 links
Journal of Neuroinflammation
Multiple Sclerosis Research Studies
article

Betaine-linked one-carbon metabolism in demyelinating neuroinflammation: evidence boundaries and testable predictions for multiple sclerosis

Lin-Yun Chen, Jie-Qiong Lu, Xiangming Ye, Yuehua Fei, Kai-Yi Song, Min Guo, Huiqi Wang, Xiuming Guo, Yi-Jie Wu, Fei-Na Shu
article en

Abstract

Abstract Background Multiple sclerosis (MS) involves peripheral immune activation, central nervous system (CNS) inflammation, and incomplete repair. This narrative review integrates evidence on betaine-linked one-carbon metabolism across adaptive immunity, lesion-associated myeloid cells, and the oligodendrocyte lineage to identify supported mechanisms, unresolved connections, and priorities for experimental validation. Main body Betaine contributes to systemic homocysteine remethylation through betaine-homocysteine methyltransferase (BHMT), which is expressed predominantly in the liver and kidney. In a high-dose experimental autoimmune encephalomyelitis (EAE) study, preventive betaine treatment reduced disease severity, dendritic cell interleukin-6 production, and T helper 17 (Th17) differentiation; treatment after disease onset did not improve established disease. Independent methionine restriction experiments demonstrated regulation of T-cell S-adenosylmethionine availability and inflammatory chromatin programming. Together, these studies identify immune signaling and methionine-dependent epigenetic regulation as complementary subjects for mechanistic investigation, with cellular activation state and methylation target guiding interpretation. Studies using cuprizone models reported metabolic, neuronal, inflammatory, and structural outcomes, while oligodendrocyte experiments identified maturation-related molecular responses. Betaine studies in predominantly non-MS microglial models provide a rationale for examining inflammatory signaling in demyelinating settings. A descriptive audit of selected public human brain transcript resources identified sparse BHMT transcript detection, informing priorities for protein localization and enzyme activity studies in MS lesion cells. Human dietary and metabolite studies provide association-level evidence, while human pharmacology characterizes systemic exposure and biochemical responses and informs safety monitoring. Conclusions This review integrates the available evidence into a testable framework that distinguishes systemic metabolism from cell-intrinsic mechanisms and considers cellular activation state. The examined EAE evidence identifies dendritic cell-derived interleukin-6 as an experimentally supported betaine-linked immune entry point, while hepatic mediation remains a separate hypothesis. Matched interventions, cell-resolved flux measurements, and selective perturbations would help distinguish immune modulation, tissue preservation, and remyelination. This framework provides a focused research agenda for determining whether and how betaine-linked metabolism influences demyelinating neuroinflammation and its relevance to MS.

Journal of Neuroinflammation
Wenzhou Medical University (CN), Jinhua Academy of Agricultural Sciences (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Zhejiang Provincial People's Hospital (CN), Hangzhou Hospital of Traditional Chinese Medicine (CN), Jinhua Central Hospital (CN), Affiliated Hospital of Jining Medical University (CN), Hangzhou Medical College (CN)
Good health and well-being
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon